Treatment of clinical hypothyroidism with thyroxine and triiodothyronine: A literature review and metaanalysis

Psychosomatics

Volumn 48, Issue 5, 2007, Pages 379-384

  Joffe, Russell T ^a   Brimacombe, Michael ^b   Levitt, Anthony J ^b   Stagnaro Green, Alex ^b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; LIOTHYRONINE; THYROXINE;

CLINICAL TRIAL; COGNITION; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; HUMAN; HYPOTHYROIDISM; MENTAL DISEASE; META ANALYSIS; MONOTHERAPY; MOOD DISORDER; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 34548291456     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.48.5.379     Document Type: Review

References (22)

1. Singer PA, Cooper DS, Levy EG, et al: Treatment guidelines for patients with hyperthyroidism and hypothyroidism. JAMA 1995; 273:808-812
2. Stock JM, Surks MI, Oppenheimer JN: Replacement dosage of L-thyroxine in hypothyroidism: a re-evaluation. N Engl J Med 1974; 290:529-533
3. Escobar-Morreale HF, Botella-Carratero I, Gomez-Bueno M, et al: Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone. Arch Intern Med 2005; 142:412-424
4. Saravanan P, Chau W-F, Roberts N, et al: Psychological well-being in patients on "adequate" doses of L-thyroxine: results of a large, controlled, community-based questionnaire. Clin Endocrinol 2002; 57:577-585
5. Joffe RT, Sokolov SH: Thyroid hormone treatment of primary unipolar depression: a review. Int J Neuropsychopharmacol 2000; 3:143-147
6. Baumgartner A: Thyroxine and the treatment of affective disorders: an overview of the results of basic and clinical research. Int J Neuropsychopharmacol 2000; 3:149-165
7. Cooper DS: Combined T4 and T3 therapy: back to the drawing board (editorial). JAMA 2003; 290:3002-3004
8. Walsh JP: Dissatisfaction with thyroxine therapy: could the patients be right? Curr Opin Pharmacol 2002; 2:717-722
9. Canaris GJ, Manowitz NR, Mayor G, et al: The Colorado Thyroid Disease Prevalence Study. Arch Intern Med 2000; 160:526-534
10. Bunevicius R, Kazanavicius G, Zalinkevicius R, et al: Effects of thyroxine as compared with thyroxine-plus-triiodothyronine in patients with hypothyroidism. N Engl J Med 1999; 340:424-429
11. Clyde PW, Harari AE, Getka EJ, et al: Combined levothyroxine-plus- liothyronine compared with levothyroxine-alone in hypothyroidism: a randomized, controlled trial. JAMA 2003; 290:2952-2958
12. Walsh JP, Shiels L, Lim EM, et al: Combined thyroxine/liothyronine treatment does not improve well-being, quality of life, or cognitive function compared to thyroxine-alone: a randomized, controlled trial in patients with primary hypothyroidism. J Clin Endocrinol Metab 2003; 88:4543-3550
13. Sawka AM, Gerstein HC, Marriott MJ, et al: Does a combination regimen of thyroxine (T4) and 3,5,3′-triiodothyronine improve depressive symptoms better than T4-alone in patients with hypothyroidism? results of a double-blind, randomized trial. J Clin Endocrinol Metab 2003; 88:4551-4555
14. Siegmund W, Spieker K, Weike AI, et al; Replacement therapy with levothyroxine-plus-triiodothyronine (bioavailable molar ratio 14:1) is not superior to thyroxine-alone to improve well-being and cognitive performance in hypothyroidism. Clin Endocrinol 2004; 60:750-757
15. Escobar-Morreale HF, Botella-Carratero JI, Escobar Del Ray F, et al: Review: treatment of hypothyroidism with combinations of levothyroxine and liothyronine. J Clin Endocrinol Metab 2005; 90:4046-4954
16. Appelhof BC, Fliers E, Wekking EM, et al: Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial. J Clin Endocrinol Metab 2005; 90:2666-2674
17. Applehof BC, Peeters RP, Wiersinga WM, et al: Polymorphisms in Type 2 deiodinase are not associated with well-being, neurocognitive functioning, and preference for combined thyroxine/ 3,5,3′-triiodothyronine therapy. J Clin Endocrinol Metab 2005; 90:6296-6299
18. Saravanan P, Simmons DJ, Greenwood R, et al: Partial substitution of thyroxine (T4) with triiodothyronine in patients on T4 replacement therapy: results of a large, community-based, randomized, controlled trial. J Clin Endocrinol Metab 2005; 90:805-812
19. Fleiss JL: The statistical basis of meta-analysis. Statistical Methods in Medical Research 1993; 2:121-145
20. Klein I: T3 and T4: are we missing half the picture? Clinical Cornerstone 2005; 7:S5-S7
21. Hennemann G, Cocter R, Visser TJ, et al: Thyroxine plus low-dose, slow-release triiodothyronine replacement in hypothyroidism: proof of principle. Thyroid 2004; 14:271-275
22. Wartofsky L: Combined levotriiodothyronine and levothyroxine therapy for hypothyroidism: are we a step closer to the magic formula? Thyroid 2004; 14:247-248